(Q44936792)

English

A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

A comparison of (111)In-DOTATOC and (111)In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

F Forrer

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

H Uusijärvi

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

C Waldherr

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Cremonesi

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

P Bernhardt

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

J Mueller-Brand

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

H R Maecke

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

10 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1257-1262

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-004-1553-6

0 references

Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biokinetics and dosimetry in patients administered with (111)In-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with (90)Y-DOTATOC

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

90Y-DOTA-D-Phe1-Try3-octreotide in therapy of neuroendocrine malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 DOTATOC: first clinical results

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple actions of somatostatin in neoplastic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/15197500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-004-1553-6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44936792&oldid=2058765830"